[The mRNA vaccine for the treatment of pancreatic cancer is here to stay]

Medicina (B Aires). 2023;83(4):650-652.

[Article in Spanish]

Authors

Eduardo Chuluyan¹, Carlos Davio², Nelson Dusetti², Nicolás Fraunhoffer², María Noé Garcia², Juan Garona², Betina González², Florencia Gottardo², Daniel Grasso², Juan Iovanna², Gustavo Kohan², Paul Eduardo Lada², Oscar Mazza², Martín Monte², Daniela Papademetrio², María Eugenia Pasqualini², Ana Sahores², Patricia Santofimia², Agustín Yaneff²

Affiliations

¹ Red Franco Argentina para el Cáncer de Páncreas. E-mail: echuluyan@gmail.com.
² Red Franco Argentina para el Cáncer de Páncreas.

PMID: 37582144

No abstract available

Publication types

Letter

MeSH terms

Cancer Vaccines* / therapeutic use
Humans
Pancreatic Neoplasms* / genetics
Pancreatic Neoplasms* / therapy
Vaccines, Synthetic
mRNA Vaccines

Substances

Vaccines, Synthetic
Cancer Vaccines